Preventing Heart Attacks and Deaths with Nexlotol

Welcome to Heart Doc VIP with Dr. Joel Kahn, where we bring you the latest insights on heart health. In this episode, we delve into the remarkable findings of the CLEAR study, a groundbreaking research endeavor involving over 4,000 volunteers. Dr. Kahn sheds light on how Nexlotol (bempadoic acid), taken orally, demonstrates the potential to prevent death in individuals who have never experienced a heart attack, stent, or bypass operation. The results are both impressive and meaningful, offering hope for improved cardiac outcomes.

But that's not all. Dr. Kahn dives into other compelling studies that explore the relationship between meat consumption and heart disease, the impact of atrial fibrillation on women's memory, the connection between atrial fibrillation and Omega-3 levels, and the intriguing link between wine and heart health. 

This episode of Heart Doc VIP is proudly sponsored by healthycell.com, presenting their innovative gel vitamin line. Say goodbye to cumbersome capsules and embrace the ease of one gel shot. As a special offer, use the code KAHN to enjoy a 20% discount on your purchase. 

Wishing everyone a Happy and Healthy July 4th weekend. Let Freedom Ring!